Point Of Care Diagnostics Industry PowerPoint PPT Presentations

Data Bridge Market Research analyses that the point of care diagnostics market is expected to reach the value of USD 68.21 billion by the year 2029, at a CAGR of 9.1% during the forecast period. The rising prevalence of infectious diseases in developing countries is propelling the point-of-care diagnostics market.

Data Bridge Market Research analyses that the point of care diagnostics market is expected to reach the value of USD 68.21 billion by the year 2029, at a CAGR of 9.1% during the forecast period.

The point-of-care diagnostics market is expected to witness market growth at a rate of 10.22% in the forecast period of 2022 to 2029. Data Bridge Market Research report on point-of-care diagnostics market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the incidence of target diseases is escalating the growth of point-of-care diagnostics market.

The Point of care diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 816.12 million by 2028. Increasing prevalence of chronic diseases and rising preference for homecare testing are anticipated to drive the growth of the market.

North America point-of-care diagnostics market is expected to witness market growth at a rate of 9.24% in the forecast period of 2021 to 2028.

North America point-of-care diagnostics market is expected to witness market growth at a rate of 9.24% in the forecast period of 2021 to 2028.

Middle East and Africa point-of-care diagnostics market is expected to reach USD 2,064.86 million by 2028, growing with a CAGR of 6.1% in the forecast period of 2021 to 2028

Middle East and Africa point-of-care diagnostics market is expected to reach USD 2,064.86 million by 2028, growing with a CAGR of 6.1% in the forecast period of 2021 to 2028

Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027

Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.

Reason behind Care Testing permits doctors and clinical staff to precisely accomplish continuous, lab-quality demonstrative outcomes in no time. By utilizing compact blood analyzers, Checking at the "place of treatment" works on the determination cycle. While diagnosing a patient's condition or observing a treatment reaction, POC testing permits staff to pursue fast essential consideration and treatment choices.

The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.

According to Straits Research, the global point-of-care molecular diagnostics market size was valued at USD 2.27 billion in 2022 and is projected to reach USD 4.48 billion by 2031, growing at a CAGR of 7.84% during the forecast period (2023–2031). https://straitsresearch.com/report/point-of-care-molecular-diagnostics-market/request-sample

The global point of care diagnostics market was valued at US$ 17,886.3 Mn 2018 and is expected to reach US$ 30,175.3 Mn 2026, growing at a CAGR of 6.8% during the forecast period.

The global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.

Read More: https://www.theinsightpartners.com/reports/point-of-care-molecular-diagnostics-market/

Point of Care Molecular Diagnostics market research report identifies overall market share, market size, and revenue potential guiding companies on market economics. Read More @ https://www.theinsightpartners.com/reports/point-of-care-molecular-diagnostics-market/

Global Point of Care Diagnostics Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

According to the latest research report by IMARC Group, The global point of care molecular diagnostics market size reached US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.2% during 2024-2032. More Info:- https://www.imarcgroup.com/point-of-care-molecular-diagnostics-market

The global point-of-care diagnostics devices and equipment market size will grow from $28.47 billion in 2022 to $32.34 billion in 2023 at a compound annual growth rate (CAGR) of 13.6%.

Veterinary Point-of-Care Diagnostics Market 2020 global industry research report is a professional and in-depth study on the Veterinary Point-of-Care Diagnostics Market trends, share, size, growth, as well as industry analysis. The emergence of COVID-19 has brought the world to a standstill.

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018

Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.

Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories.

Increasing incidence of infectious diseases and cancer, rising demand for diagnostics point-of-care is driving the demand for the market.

The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161

Point of Care Diagnostics (POCD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostics (POCD) market will be able to gain the upper hand as they use the report as a powerful resource.

The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.

Point of Care Diagnostics (POCD) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostics (POCD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Allied Market Research has recently published a report on the point of care diagnostics market, which is a comprehensive study of the entire industry for the period of 2014–2022.

Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.

A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.

The Global Point of Care (PoC) molecular diagnostics market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.

Point-of-Care Diagnostics Market report categories the Global market by End Users (Hospitals, Home, Ambulatory Care), Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), Over-the- Counter, Prescription Based & Geography

Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report

The global market size of Point of Care (PoC) Molecular Diagnostics is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.

Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.

[191 Pages Report] Biosensors market research report categorizes global market by application (point of care, home diagnostics, research labs, biodefense, environmental monitoring, food industry), product (wearable, non-wearable), technology (electrochemical, piezoelectric, optical) & geography

In this report, the global Point of Care Diagnostics Market was valued at US$ 17,886.3 Mn 2018 and is projected to reach US$ 30,175.3 Mn by the end of 2027, growing at a CAGR of 6.8% during the period 2018 to 2027

[191 Pages Report] Biosensors market research report categorizes global market by application (point of care, home diagnostics, research labs, biodefense, environmental monitoring, food industry), product (wearable, non-wearable), technology (electrochemical, piezoelectric, optical) & geography

The biosensor is a sensing device, which consists of a combination of a specific biological element and a transducer. This market is expected to witness a prominent growth over the coming years. Driven by the need for better methods for environmental monitoring and rapid pathogen detection, the biosensors industry has also been expanding to encompass non-clinical applications such as biodefense, environmental surveillance, and food industry.

Global POC Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. Single user License: US $3000; Buy a copy of report @ http://www.reportsnreports.com/Purchase.aspx?name=344547.

The Italy point-of-care glucose testing market has been witnessing significant growth during the forecast period, owing to increase in investments in healthcare infrastructure and rise in awareness for diabetes treatment. Moreover, technological advancements are driving the market growth.

Global in-vitro diagnostics market size is expected at $148.58 bn by 2027 at a growth rate of 8.7%. and growth and demand by The Business Research Company.

In Vitro Diagnostics Market USD 102.18 billion in 2024, poised for significant growth to USD 131.66 billion by 2029, with a notable CAGR of 5.20%. The catalyst for this growth is the global response to the COVID-19 pandemic.

The Business Research Company offers veterinary infectious disease diagnostics market research report 2023 with industry size, share, segments and market growth

MarketReportsOnline.com adds In-Vitro Diagnostics Market Global Briefing 2017 Including: Point-of-Care Diagnostics, Immunochemistry, Molecular Diagnostics, Microbiology, Hematology and Immunohematology Covering: Siemens Healthineers, Abbott Laboratories Inc., Thermo Fisher Scientific, Inc., Sysmex Corporation research report of 26 pages on the in-vitro diagnostics industry to the healthcare intelligence collection of its research store. Place a Direct Purchase order on In-Vitro Diagnostics Market Research Report at USD 1000 (Single User License) http://www.marketreportsonline.com/contacts/purchase.php?name=568065.

iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

Point of Care (POC) Diagnostic Devices Market Size is estimated to reach $48.9 billion by 2027 and it is poised to grow at a CAGR of 6.2% over the forecast period of 2022-2027.

This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8

According to the latest research report by IMARC Group, The global poultry diagnostics market size reached US$ 441.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 791.2 Million by 2028, exhibiting a growth rate (CAGR) of 10.2% during 2023-2028. More Info:- https://www.imarcgroup.com/poultry-diagnostics-market

Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.

According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market

The global veterinary infectious disease diagnostics market size was USD 1.70 Billion in 2021 and is expected to register a revenue CAGR of 9.1% during the forecast period, according to the latest analysis by Emergen Research. Revenue growth of the veterinary infectious disease diagnostics market is driven by factors such as rising number of veterinary practitioners in developed countries, increasing prevalence of transboundary & zoonotic disease, and rising demand for pet insurance, advanced diagnostic devices, companion animal, and animal-derived food products.

A recent report published by The Business Research Company on In-Vitro Diagnostics Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/2WKIWmk

Personalized Medicine diagnostics market is expected to grow with a double digit CAGR for the period of 2013 to 2018. It is expected that personalized medicine diagnostics market by technology is going to double by 2018 from its current market size in 2012. In this segment, Point of Care Testing and Molecular Diagnostics segments control the #1 and #2 positions in 2012.